Dengvaxia Archives -

The US regulator has started a priority, six-month review of Takeda’s dengue fever vaccine TAK-003 – tipped as

FDA starts speedy review of Takeda’s dengue vaccine

https://pharmaphorum.com/news/fda-starts-speedy-review-of-takedas-dengue-vaccine/

Japan’s Takeda has secured its first regulatory approval – in Indonesia – for its dengue fever vaccine TAK-003,

Takeda gets first approval for its dengue vaccine

https://pharmaphorum.com/news/takeda-gets-first-approval-for-its-dengue-vaccine/

Takeda has reported positive new, long-term results in its pivotal trial of dengue fever vaccine TAK-003 that builds

Takeda bolsters data for dengue jab as regulatory reviews roll on

https://pharmaphorum.com/news/takeda-bolsters-data-for-dengue-jab-as-regulatory-reviews-roll-on/

Takeda has revealed long-term clinical trial results with its dengue vaccine that reinforce its safety and efficacy –

After Sanofi’s setbacks, Takeda eyes finish line with its dengue vaccine

https://pharmaphorum.com/news/after-sanofis-setbacks-takeda-eyes-finish-line-with-its-dengue-vaccine/

Burden of Dengue fever far greater than Zika

Brazil begins dengue immunisation with Sanofi’s Dengvaxia

https://pharmaphorum.com/news/brazil-begins-dengue-immunisation-sanofis-dengvaxia/

Dengvaxia